Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

ImmunityBio, Inc. (IBRX) News - StockMarketCap

Stocks›ImmunityBio, Inc.☆

● At closeAs of Jul 2, 2026

ImmunityBio, Inc.

IBRX✓

HealthcareBiotechnologyNASDAQ

$9.44+2.61%

$9.89BMarket cap

-10.24xP/E ratio

14.55MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$9.44

$0.24 (+2.61%) · 24h

Key metrics

Market cap$9.89B+20.99%

Enterprise value$10.07B

Volume (24h)14.55M

P/E ratio (TTM)-10.24x

P/S ratio (TTM)64.93x

Dividend yield0.00%

Shares outstanding1.05B

Trading range

Previous close$9.20

Day range$9.03 - $9.60

52-week range$1.95 - $12.43

ImmunityBio, Inc. (IBRX) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news